Nevertheless, we validated the anti-tumor effects of CD276 CAR-T and Dash CAR-T against pancreatic cancer in preclinical studies and demonstrated that CD276 Dash CAR-T may be a potential treatment for pancreatic cancer patients. Here, CD276 is linked to neoplasm.